Pharmacokinetics of deslanatoside C-3H administered parenterally to the guinea-pig, rabbit and dog.
The pharmacokinetics of Deslanatoside C-3H, a short-acting polar cardiac glycoside, were investigated in the guinea-pig, rabbit and dog, after parenteral administration. Deslanatoside C was on average 20% plasma protein-bound and had a red blood celle/plasma partition ratio of 1/9. Tissue uptake of Deslanatoside C observed in the guinea-pig seems on average to be higher than in rabbits. Among the various organs and fluids tested, the highest levels were encountered in the urine, bile and kidneys of both the guinea-pig and rabbit. The main excretory route of this glycoside was via the urine, although significant amounts were excreted via the bile in all the three species tested. Cumulative urinary excretion 24 hr after i.v. injection was 50% (75% of which in unchanged form) in the guinea-pig, 46.5% (86% of which in unchanged form) in the rabbit, and 42.9%(84% of which in unchanged form) in the dog. Among the cardiac glycosides, Deslantoside C seems to possess the highest urinary excretion rate, which has in fact also recently been confirmed in human subjects.
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D003892:Deslanoside / Q000008:administration & dosage / Q000378:metabolism*; D004285:Dogs; D004355:Drug Stability; D004912:Erythrocytes / Q000378:metabolism; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007700:Kinetics; D007799:Lanatosides / Q000378:metabolism*; D011485:Protein Binding; D011817:Rabbits; D013045:Species Specificity
D001798:Blood Proteins; D007799:Lanatosides; D003892:Deslanoside